Universal Leaf Tobacco Company account plan
Global leaf tobacco supplier
At a glance
Universal Corporation is a Richmond, Virginia leaf tobacco supplier and plant-based ingredients maker with $2,924.5 million of FY2026 revenue.
Universal Corporation (NYSE: UVV) is a business-to-business agriproducts company based in Richmond, Virginia, that sources, processes and sells leaf tobacco and plant-based ingredients to consumer product manufacturers in over 30 countries on five continents; it sells no direct-to-consumer products. In FY2026 (year to March 31, 2026) revenue was $2,924.5 million (-1%), operating income $168.5 million (-28%) and net income attributable $32.6 million vs $95.0 million. Its six largest customers (Altria, BAT, China Tobacco International, Imperial Brands, Japan Tobacco and Philip Morris International) account for about 60% of revenue. It employs more than 25,000 people, about 55% of them seasonal, and contracts with over 200,000 farmers.
Business units
Tobacco Operations (Universal Leaf Tobacco Company)
about 88% of FY2026 revenue ($2,576.4 million)Procures, processes, packs and ships flue-cured, burley, dark air-cured and oriental leaf for cigarette and next-generation product makers, plus services such as custom blending, testing, reconstituted sheet and liquid nicotine through AmeriNic. It operates in all major origins, from Brazil and the United States to Malawi, Mozambique and the Philippines, and its principal competitor is Pyxus International. FY2026 segment operating income was $211.5 million, down on dark air-cured write-downs of $43.4 million.
Ingredients Operations (Universal Ingredients)
about 12% of FY2026 revenue ($348.1 million)Makes fruit and vegetable juices, concentrates, dehydrated products, botanical extracts, flavorings and colorings through FruitSmart, Silva and Universal Ingredients-Shank's, for packaged-goods, beverage, food service and pet food customers. Segment operating income fell to $3.2 million in FY2026 (-74%) and the unit took a $41.1 million goodwill impairment at Shank's. It is led by J. Patrick O'Keefe, Vice President, Ingredients, and has been reorganized around Fruit, Dry and Taste solutions.
Strategic priorities
- Maximize and optimize Tobacco
- Grow volume, market share and services across customers' supply chains, including next-generation products such as heat-not-burn leaf, liquid nicotine and flavors.
- Bring uncommitted inventory back into range
- The company targets committed inventory of 80% or more; uncommitted tobacco inventory fell from about 27% at March 31, 2026 to about 19% at September 30, 2026, back within target.
- Turn around Universal Ingredients
- The ingredients platform is being transformed into a more integrated and aligned organization, a process expected to run through fiscal year 2028, with a focus on commercial execution and facility utilization at Shank's.
- Delever the balance sheet
- With smaller crops expected, the CFO aims to reduce net debt, which stood at $1,154.2 million (45% of net capitalization) at September 30, 2026, and cut interest expense.
- Strengthen the company for the next 100 years
- The third strategic pillar covers financial management, human capital, technology including AI, synergies between segments and sustainability, with net zero across the value chain by 2050.
Latest results
In Q2 FY2027 (quarter to September 30, 2026) revenue fell 18% to $621.8 million and operating income 37% to $42.6 million, with adjusted diluted EPS of $0.39 vs $1.36. Tobacco revenue was $534.3 million (-19%) on 23% lower sales volumes as customers committed later in an oversupplied market, and Ingredients revenue was $87.5 million (-8%) with an operating loss of $2.1 million. First-half revenue was $1,145.6 million (-15%). Management expects shipments to be heavily weighted to the second half and keeps gross margin guidance in the 17%-19% range and SG&A at $300-310 million.
Investments and deals
- Capital expenditure
- Capex was $53.5 million in FY2026; $60-70 million is expected over the twelve months following September 30, 2026.
- Refinanced bank facilities
- A December 9, 2025 agreement provides $275 million and $345 million term loans and a $780 million revolver; an October 9, 2026 amendment temporarily raised the covenant leverage level through March 31, 2027.
- Share repurchase program
- A new program of up to $100 million, approved November 4, 2026, runs to November 15, 2028.
- European sheet tobacco consolidation
- Sheet operations were consolidated into the Netherlands, with the German facility wound down; the sale of a closed sheet facility brought $2.7 million of restructuring income in Q2 FY2027.
Challenges and risks
- Leaf tobacco oversupply
- Flue-cured crops outside China rose about 28% and burley about 54% in FY2026, and both styles are expected to stay oversupplied in FY2027, slowing customer commitments.
- Customer concentration
- The six largest customers account for about 60% of revenue, with Philip Morris International alone about $620 million in FY2026.
- Ingredients losses
- Weak consumer packaged goods demand, tariffs, tight Pacific Northwest apple supplies and fixed costs of the Lancaster expansion pushed the segment to a first-half operating loss of $2.7 million.
- Logistics for second-half shipments
- Management flagged port congestion and ship and container availability given the large volumes to move in the second half.
- Cost inflation and tariffs
- The 2025 US tariffs and the armed conflict involving Iran raised logistics, fertilizer and fuel costs that the company may not fully pass on.
What leadership says
“century of experience and market leadership have prepared us well to navigate the current tobacco market cycle”
“we aim to take this opportunity to delever our balance sheet and reduce interest expense to support earnings per share and dividend coverage ratios.”
“we are absolutely committed to growing our ingredients business in particular in Shanks”
“deliver dependable free cash flow and balance sheet through disciplined capital allocation”
Where a supplier can help
- Freight and port capacity
- Tied to the second-half logistics challenge: logistics and shipping partners that secure vessel and container capacity for heavily back-loaded tobacco shipments.
- Commercial execution in ingredients
- Tied to the Universal Ingredients transformation: sales, R&D and marketing support that converts customer interest into volume and improves utilization at Shank's.
- Working capital and treasury tools
- Tied to the deleveraging priority: forecasting, inventory and cash management solutions that help reduce net debt and interest expense.
- AI and technology
- Tied to the pillar of strengthening the company, which explicitly includes expanding the use of AI and synergies between segments.
- Sustainable farming programs
- Tied to the net-zero-by-2050 target and regenerative agriculture work with customers: suppliers of renewable energy, efficient curing barns and supply chain due diligence.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Universal Leaf Tobacco Company?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Universal Corporation Form 10-K for the fiscal year ended March 31, 2026
- Universal Corporation (NYSE: UVV), Richmond, Virginia, is a business-to-business agriproducts company and "the leading global leaf tobacco supplier", operating in over 30 countries on five continents; it sells no direct-to-consumer products. Its main subsidiaries are Universal Leaf Tobacco Company, Incorporated (tobacco) and Universal Ingredients, Inc. (ingredients).
- FY2026 (year to March 31, 2026): revenue $2,924.5 million (-1%), operating income $168.5 million (-28%), adjusted operating income $211.3 million (-13%), diluted EPS $1.30 (adjusted $2.64, vs $4.63), net income attributable $32.6 million vs $95.0 million.
- Two segments: Tobacco Operations (revenue $2,576.4 million, operating income $211.5 million) and Ingredients Operations (revenue $348.1 million, operating income $3.2 million, -74%).
- Results were hit by a $41.1 million non-cash goodwill impairment at Universal Ingredients-Shank's and by $52.0 million of inventory write-downs, mainly non-wrapper dark air-cured tobacco.
- Very concentrated customer base: the six largest customers (Altria, BAT, China Tobacco International, Imperial Brands, Japan Tobacco, Philip Morris International) account for about 60% of revenue; PMI alone about $620 million and Imperial about $400 million in FY2026.
- Market turned to oversupply: flue-cured crops outside China rose about 28% to 2.4 billion kilos and burley about 54% to 722 million kilos; uncommitted tobacco inventory rose to $222.3 million (about 27% of tobacco inventory) against a target of committed inventory of 80% or more.
- Strategy rests on three pillars: maximizing and optimizing Tobacco, growing Ingredients, and strengthening the company for the future (financial management, human capital, technology including AI, synergies between segments).
- Balance sheet: net debt $845.5 million (37% of net capitalization); new December 2025 bank agreement ($275 million and $345 million term loans plus a $780 million revolver); FY2027 capex planned at $55-65 million; $81.3 million of dividends paid, no buybacks.
- Workforce of more than 25,000 employees, about 55% seasonal; less than 5% are in the United States. Over 200,000 contracted farmers; net-zero by 2050 target approved by SBTi.
- Universal Corporation Form 10-Q for the quarter ended September 30, 2026 (Q2 fiscal 2027)
- Q2 FY2027 (quarter to September 30, 2026): revenue $621.8 million (-18%), operating income $42.6 million (-37%), net income attributable $12.6 million vs $34.2 million, diluted EPS $0.50 (adjusted $0.39 vs $1.36).
- First half: revenue $1,145.6 million (-15%), operating income $44.9 million (-56%), adjusted EPS $0.19 vs $1.74.
- Tobacco Operations revenue $534.3 million (-19%) on 23% lower sales volumes from a delayed oversupply market cycle (prices +3% on mix); segment operating income $43.9 million vs $65.2 million.
- Ingredients Operations revenue $87.5 million (-8%) on tight Pacific Northwest apple supplies and high raw material costs; operating loss $2.1 million.
- Uncommitted tobacco inventory down to $229.5 million, about 19% of tobacco inventory (27% at March 31, 2026), within target; shipments expected to be heavily weighted to the second half, with emerging customer interest in extra volumes because of El Niño concerns.
- Net debt $1,154.2 million, 45% of net capitalization; covenant leverage level temporarily raised by an October 9, 2026 amendment through March 31, 2027.
- Universal Ingredients is being transformed into a more integrated organization, a process expected to run through fiscal year 2028.
- New $100 million share repurchase program approved November 4, 2026, running to November 15, 2028; capex of $60-70 million expected over the next twelve months.
- Universal Corporation Q2 fiscal 2027 earnings call transcript
- Q2 FY2027 call (November 5, 2026): CEO Preston Wigner says first-half results reflect "the slower timing of tobacco shipments within the delayed oversupply cycle"; customer commitments remain in line with the full-year sales plan.
- Uncommitted inventory fell to 19% at September 30, within target; worldwide unsold flue-cured and burley stocks about 134 million kilos, down about 45 million kilos from June 30.
- El Niño concerns are creating customer interest in additional volumes, which would be in addition to the sales plan; management will not quantify it yet.
- Tobacco Q2 revenue $534 million (-19%), segment operating income $44 million vs $65 million; Ingredients revenue $88 million (-8%), operating loss $2 million.
- Ingredients reorganized around "Fruit, Dry, and Taste solutions"; transformation continues through next fiscal year; Shank's capacity utilization "not where I want it to be".
- CFO Steven Diel: net debt $1.15 billion, liquidity about $945 million; with smaller crops expected, the aim is to "delever our balance sheet and reduce interest expense".
- Guidance points: gross margin in the 17%-19% range, SG&A $300-310 million still fair; tobacco operating margin expected to improve in the second half.
- Watch-points: port congestion and ship and container availability for the large second-half shipments; the Brazilian real against the dollar.
- 100th anniversary as a NYSE-listed company next November; 56 consecutive years of annual dividend increases.
- Universal Corporation Q4 fiscal 2026 earnings call transcript
- Q4/FY2026 call (May 29, 2026), the first with Steven Diel as CFO (effective April 1; at Universal since 2018).
- FY2026 revenue $2.9 billion, operating income $169 million (down $64 million), net income $33 million vs $95 million; Q4 operating loss $15 million and net loss $43 million.
- Two drags: a $41 million non-cash goodwill impairment at Shank's (acquired October 2021) and tobacco inventory write-downs of $43 million, mostly non-wrapper dark air-cured, vs a five-year average of $14 million.
- Wigner: the market went from "undersupply to balance to oversupply all at 1 time"; he is confident uncommitted inventory (27% at March 31) will be back within the 10%-20% range during fiscal 2027.
- In oversupply Universal can be "more intentional, more strategic" in buying grades at the right prices and gains third-party processing from larger crops.
- Shank's: leadership-level realignment focused on commercial execution, facility utilization and efficiency; no acquisitions since 2021, the focus is now on returns from organic investment.
- Capital allocation unchanged (invest in tobacco, grow the dividend, ingredients growth, buybacks); payout ratio over 100% of reported FY2026 net income but below 75% of adjusted net income over five years; 56th consecutive annual dividend increase.
- Net debt $845 million; liquidity over $1.2 billion. CDP supplier engagement rating raised to A.
- Universal Corporation Q3 fiscal 2026 earnings call transcript
- Q3 FY2026 call (February 9, 2026) with CEO Preston Wigner and outgoing CFO Johan Kroner; Steven Diel announced as CFO effective April 1.
- Nine months to December 31, 2025: revenue $2.21 billion vs $2.25 billion, operating income $183.4 million vs $190 million, net income $75.9 million vs $85.7 million.
- Q3 revenue $861.3 million vs $937.2 million; tobacco revenue $779.9 million, segment operating income $84 million vs $102.6 million; Ingredients revenue $81.3 million with a $100,000 operating loss.
- Wigner: the leaf market is "moving into an oversupply environment"; tobacco year-to-date numbers are the second highest of the last four years despite comparison with an "extraordinary" fiscal 2025.
- Ingredients hit by weak consumer packaged goods demand, direct and indirect tariff impacts and fixed costs of the Lancaster expansion; ingredients sales up 7% year to date.
- Credit facility refinanced and upsized by $250 million; net debt $995 million at December 31, 2025; liquidity $917 million.
- Strategy: participate in the next-generation supply chain (heat-not-burn leaf, liquid nicotine, flavors); 17.7% renewable electricity and net zero by 2050.
Questions about Universal Leaf Tobacco Company
What does Universal Corporation do?
It is a business-to-business agriproducts company that buys, processes and sells leaf tobacco to cigarette and nicotine product manufacturers and makes plant-based food and beverage ingredients. It operates in over 30 countries on five continents.
What is Universal Corporation's revenue?
Revenue was $2,924.5 million in FY2026 (year to March 31, 2026), with operating income of $168.5 million. In the first half of FY2027 revenue was $1,145.6 million (-15%).
How many employees does Universal Corporation have?
More than 25,000, about 55% of them seasonal; less than 5% work in the United States.
Who leads Universal Corporation?
Preston D. Wigner has been Chairman, President and CEO since October 2024; Steven S. Diel became Senior Vice President and CFO in April 2026.
What is Universal Corporation's strategy?
Three pillars: maximizing and optimizing Tobacco, growing Ingredients, and strengthening the company for the future, including financial management, human capital and technology such as AI.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)